Medical Communications

Showing 15 posts of 6408 posts found.

shutterstock_92671375

Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions

January 23, 2020 Medical Communications, Sales and Marketing insys, pharma

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …
shutterstock_95714119

Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis

January 23, 2020 Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …
gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

January 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …
steven_hildemann

Ipsen appoints new Exec VP and Chief Medical Officer

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …
4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …
landing-hero-images1

Japan welcomes approval of ViiV’s Dovato for HIV-1

January 17, 2020 Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …

UK trial aims to find treatments that can slow or reverse motor neurone disease

January 17, 2020 Medical Communications MND, Motor Neurone, clinical trial, motor neurone disease, trial

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …
mask-1954673_1280

China’s viral pneumonia spreads to Japan

January 17, 2020 Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …
novo_nordisk_flag

Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD

January 17, 2020 Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma

Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
1201709115_133b3927a3_b

Bayer and Exscientia to work together on AI in cardiovascular and oncology drug discovery

January 10, 2020 Medical Communications Bayer, Exscientia, oncology

Bayer AG has partnered with Exscientia to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. …

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020 Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …
48612088061_36c0f87278_b

Idorsia reveals it is working with Neurocrine on new epilepsy drug deal

January 10, 2020 Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma

Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …

US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy

January 10, 2020 Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma

The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
The Gateway to Local Adoption Series

Latest content